Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer. - Wikidata - awgldk - TriplyDB

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer.

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer.

http://www.wikidata.org/entity/Q33594473

about

CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment Distribution of PDIA3 transcript and protein in rat testis and sperm cells The anti-aging and tumor suppressor protein Klotho enhances differentiation of a human oligodendrocytic hybrid cell line Next generation mapping reveals novel large genomic rearrangements in prostate cancer Gene expression pathways of high grade localized prostate cancer.Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2.The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.Host age is a systemic regulator of gene expression impacting cancer progression Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.An investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral Sarcophyton crassocaule on bladder cancer cells LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.Changes in the in vitro activity of platinum drugs when administered in two aliquots.Analysis of the spleen proteome of chickens infected with reticuloendotheliosis virus Changes in the transcriptome of morula-stage bovine embryos caused by heat shock: relationship to developmental acquisition of thermotolerance.Endoplasmic reticulum stress-induced apoptotic pathway and mitochondrial dysregulation in HeLa cells treated with dichloromethane extract of Dillenia suffruticosa.SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression The present and future of prostate cancer urine biomarkers.The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma.Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis.Computational Systems Biology Approach Predicts Regulators and Targets of microRNAs and Their Genomic Hotspots in Apoptosis Process.Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis.The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm.Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma.Proteomic analysis of placentas from cloned cat embryos identifies a set of differentially expressed proteins related to oxidative damage, senescence and apoptosis.Characterization of antiproliferative potential and biological targets of a copper compound containing 4'-phenyl terpyridine.Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.Dysregulated chaperones associated with cell proliferation and negative apoptosis regulation in the uterine leiomyoma.

P2860

Q28391523-30E8E9A4-CDA9-45D7-B076-D9F68B2071A3 Q28576057-660DD06F-EAF7-472A-A126-2269D9E307AB Q28817507-025A681E-FDB4-47A2-865C-FAF7B19520C9 Q33618785-00090BFB-2098-4D83-BC1A-D29734AE8515 Q33832517-69492A97-D07A-44BF-B75B-8DF49A43C657 Q34127741-0A31970D-5FB9-4A6C-B734-B7BA60EEA63F Q34143522-7B5D70D1-1F8B-4935-B490-3772988B6696 Q34518736-94560C83-F5DE-45E8-B0BE-808F94762C1A Q35428467-CDE8413C-E62C-454E-AA1F-052E792C2F98 Q35678391-4BCD585B-53DC-419F-BC43-4D8B83152421 Q35760042-DAE9AA87-4C55-4809-8D7F-E221091C58AC Q35895033-957DCBF5-7096-4EA1-A487-16B8C5FCB6FE Q36114723-813629E0-8DE6-40A2-9BFC-6244FF3E1D6D Q36252193-8AB615C9-CE3A-41A8-B0C1-AB419AD5FA65 Q36643395-2B44C33C-B081-400E-BA30-2D7B5F36246B Q36687447-6D1AE178-4B47-45F4-A9A3-7E24C630247A Q36688923-62C373F2-68F0-4851-ABBB-67F88AC62FE9 Q36697102-1F41DFC3-553E-4199-93E5-258D60CB32A2 Q37007392-841BFC63-9FAF-41C3-8710-595B6F8F9FF2 Q37667812-664BF824-8659-4C22-8DF6-434A65AF33A3 Q37957382-4C6035B1-F3CB-417B-B747-D562DB341252 Q38771004-79D53A9C-C54F-45BB-BB53-CC503BEA3525 Q38955091-6D22F7C6-EDF2-427A-BEE4-D28647CED139 Q38969401-78E9742F-5FD7-4D34-8BA3-188AAA1F04BF Q39286062-6FF494F5-F586-4BA1-BD16-5A648F236DD4 Q41557019-8B600688-2FA1-4AD4-B439-6F2C43CFBF7E Q41611254-65D7DA73-C646-40F0-BEB2-192FC42F2EFA Q51853512-F4C78CCB-DB37-43CD-80B6-E2AC80AD9D6B Q52936734-14588EF7-B89A-459B-802E-34EA69AAB696 Q55024423-8578F31D-26F9-4B5A-B31C-00C4B0F17CC7 Q55390643-F128851F-9554-452E-924D-DB6466F74102

P2860

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer.

http://www.wikidata.org/entity/Q33594473

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Differential expression of apo ...... and high-risk prostate cancer.

@ast

Differential expression of apo ...... and high-risk prostate cancer.

@en

type

label

Differential expression of apo ...... and high-risk prostate cancer.

@ast

Differential expression of apo ...... and high-risk prostate cancer.

@en

prefLabel

Differential expression of apo ...... and high-risk prostate cancer.

@ast

Differential expression of apo ...... and high-risk prostate cancer.

@en

P1433

Q33594473-2620D1C2-39B5-43F1-B243-5C649CF07014

P1476

Q33594473-2FA637E6-AC21-4855-9859-7E8DF4E8B499

P2093

Q33594473-094B6D98-3BB7-4A24-AA10-E22363952336

Q33594473-11471862-6289-4454-902F-05CBB631F97F

Q33594473-155C32F3-E787-4DD2-A68F-459C0EB89164

Q33594473-15B4E541-59B6-4C61-BFDF-970E274A3C3F

Q33594473-446E7FCB-ABA2-47AA-8509-DA10DBCEA34A

Q33594473-5A303AA1-0434-4E87-A00D-8514ADA56494

Q33594473-6110B3B4-61D5-4D65-8BDA-04AD44A6C5FA

Q33594473-F56158F8-3F49-4F77-9ECE-20F27E4BFC3E

P2860

Q33594473-04EAC6D6-DD7C-432B-9657-AEBF21125680

Q33594473-0579567B-5232-4DAC-8294-1E8414549E19

Q33594473-05EE7B5D-30F4-462E-97EF-0CA4ABA7FD3E

Q33594473-06FF4691-64AB-4F3D-9A80-B4B1ACEA1E63

Q33594473-07EF9AF2-067B-4C87-A473-85C15A93313C

Q33594473-2EC32B7D-1458-486A-8967-43105DB12C13

Q33594473-3C5E8EAF-CA71-41F6-B30B-84E87A42483C

Q33594473-486C7D91-6D99-420C-8BE3-D09A86CD1188

Q33594473-4E7E797A-37E5-4755-A138-685AE3E2006A

Q33594473-553C9D0D-F270-49AA-98DD-17950CD1012B

P2888

Q33594473-BBB0950B-0A82-4F60-9E4C-A2D83780EB99

P304

Q33594473-D4598A5A-5246-4483-926B-2B4E5BC21EF3

P31

Q33594473-5099559C-B2B6-4F4B-8992-614B81776BE8

P356

Q33594473-FB2DEB68-63A1-436F-BB87-A46B1CC169E8

P478

Q33594473-750AF88F-9F8B-4A0C-9CC1-0E07EFEE0E68

P50

Q33594473-B2497831-61BE-4CAC-BA70-4C5EC787C51E

Q33594473-EBF45FA3-1933-43CC-B1B5-DC74B5BCE090

P577

Q33594473-C9477A84-BEA7-4555-813E-1D05FABE3FD9

P5875

Q33594473-FD0F912F-8F72-4E8C-B54C-8A5C46B454BC

P6179

Q33594473-CCC6203B-1958-4B59-A1CD-7DBC321C6CDC

P698

Q33594473-02E00E0E-E8A6-4C25-9535-0EC8C1D77413

P921

Q33594473-5E710B9F-5979-4EB0-B755-C3760F0EFE99

P932

Q33594473-94579FB4-EA95-4A92-AF96-2702316D1197

P356

1476-4598-8-130

P1433

Molecular Cancer

P1476

Differential expression of apo ...... and high-risk prostate cancer.

@en

P2093

Eberhard Steiner

http://www.w3.org/2001/XMLSchema#string

Georg Bartsch

http://www.w3.org/2001/XMLSchema#string

Georg Schäfer

http://www.w3.org/2001/XMLSchema#string

Helmut Klocker

http://www.w3.org/2001/XMLSchema#string

Markus Ruschhaupt

http://www.w3.org/2001/XMLSchema#string

Nicole Chui Pressinotti

http://www.w3.org/2001/XMLSchema#string

Ruprecht Kuner

http://www.w3.org/2001/XMLSchema#string

Van-Duc Luu

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways

Significance analysis of microarrays applied to the ionizing radiation response

MatchMiner: a tool for batch navigation among gene and gene product identifiers

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Death and anti-death: tumour resistance to apoptosis

Role of the TMPRSS2-ERG gene fusion in prostate cancer

Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57

ER chaperones in mammalian development and human diseases

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

Delineation of prognostic biomarkers in prostate cancer

P2888

1476-4598-8-130

P304

130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-8-130

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Holger Sültmann

Annemarie Poustka

P577

2009-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40784388

http://www.w3.org/2001/XMLSchema#string

P6179

1033243687

http://www.w3.org/2001/XMLSchema#string

P698

20035634

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2807430

http://www.w3.org/2001/XMLSchema#string